Stake Super EOFY offer: Get $300 back for joining using the code EOFY2025. T&Cs apply.Start application

Medical Developments International Limited

1 day chart

Get A$10 trading credit to start you off

Sign up and fund a new Stake AUS account and enjoy an extra A$10 trading credit on us.

Sign up and fund a new Stake AUS account and get A$10 bonus trading credit.

T&Cs apply
Claim now
Get A$10 trading credit to start you off

About MVP

Medical Developments International Limited (MVP) is an Australian company delivering emergency medical solutions, including pain relief and respiratory products, and is dedicated to improving patient outcomes. The Company manufactures Penthrox, a non-opioid trauma & emergency pain relief product. It is approved in Australia for pain relief in settings such as hospitals, ambulance services and short procedures, in accordance with the approved Product Information.

Find out what a historical investment in Medical Developments International Limited would be worth today using our MVP stock calculator.

Sector

Health Care

CEO

Mr Brent MacGregor

Industry

Pharmaceuticals

Website

medicaldev.com

Market Capitalisation

$64M

Price-earnings ratio

-1.20

Dividend yield

-

High today

$0.57

Low today

$0.55

Open price

$0.56

52-week high

$0.94

52-week low

$0.38

Ready to start your investing journey with Stake?

Open an account

Announcements





MVP FAQs

Buying MVP shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Medical Developments International Limited in minutes.
  1. Sign up with some I.D. and zero paperwork
  2. Add funds to your account
  3. Make your first investment in MVP

The ticker symbol for Medical Developments International Limited is MVP.

One share of MVP is valued at $0.57 as of 20 June 2025.

As of 20 June 2025 Medical Developments International Limited has a market cap of $64M.

The Price to Earnings ratio of MVP is -1.20.

The Earnings Per Share of MVP is -$0.48.

The Medical Developments International Limited 52-week high stock price is $0.94.

The Medical Developments International Limited 52-week low stock price is $0.38.

Yes, the Stake investing platform allows you to buy MVP shares and over 12,000 more stocks and ETFs across the ASX and Wall St.

This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.

Invest in MVP
on Stake

Buy MVP from A$3 brokerage

Invest in 2,500+ Aussie stocks and ETFs

CHESS-sponsored ASX trades

Get started
Stake app chart
Stock shown for demonstrative purposes only. A$3 brokerage up to A$30,000.
MVP related stocks

Stake logo
Over 12,000 5-star reviews
App Store logoGoogle Play logo

Subscribe to our free newsletters

By subscribing, you agree to our Privacy Policy.

Stakeshop Pty Ltd, trading as Stake, ACN 610 105 505, is an authorised representative (Authorised Representative No. 1241398) of Stakeshop AFSL Pty Ltd (Australian Financial Services Licence no. 548196). Stake SMSF Pty Ltd ACN 648 283 532 (‘Stake Super’) is not licensed to provide financial product advice under the Corporations Act. This specifically applies to any financial products which are established if you instruct Stake Super to set up a self managed super fund (‘SMSF’). When you sign up to Stake Super, you are contracting with Stake SMSF Pty Ltd who will assist in the establishment of a SMSF under a ‘no advice model’. You will also be referred to Stakeshop Pty Ltd to enable your trading account and bank account to be set up in order to use the Stake Website and/or App. For more information about SMSFs, see our SMSF Risks page. The Stake Accumulate Fund (ARSN 680 653 374) is issued by K2 Asset Management Ltd (ABN 95 085 445 094 AFSL 244 393), a wholly owned subsidiary of K2 Asset Management Holdings Ltd (ABN 59 124 636 782). The information on our website or our mobile application is not intended to be an inducement, offer or solicitation to anyone in any jurisdiction in which Stake is not regulated or able to market its services. At Stake and Stake Super, we’re focused on giving you a better investing experience but we don’t take into account your personal objectives, circumstances or financial needs. Any advice given by Stake is of a general nature only. As investments carry risk, before making any investment decision, please consider if it’s right for you and seek appropriate taxation and legal advice. Please view our Financial Services GuideTerms & ConditionsPrivacy Policy and Disclaimers before deciding to invest on or use Stake or Stake Super. By using our website or service in any way, you agree to our Privacy Policy and Terms & Conditions. All financial products involve risk and you should ensure you understand the risks involved as certain financial products may not be suitable to everyone. Past performance of any product described on this website is not a reliable indication of future performance. Stake and Stake Super are registered trademarks in Australia.

Copyright © 2025 Stake. All rights reserved.